Sodium bicarbonate for metabolic acidosis
Abstract
Purpose of review The purpose of this review is to discuss the consequences of severe metabolic acidosis on organ function, examine the physiological controversies surrounding pH correction with sodium bicarbonate, and review the results of recent randomized clinical trials evaluating the effects of sodium bicarbonate on patient-centered outcomes in patients with metabolic acidosis. Recent findings Recent evidence has primarily focused on the results of large multicenter randomized clinical trials, which have shown that sodium bicarbonate administration does not improve mortality in unselected patients with moderate to severe metabolic acidosis, with or without acute kidney injury. However, sodium bicarbonate may delay or reduce the need for kidney replacement therapy in some patients. Summary Severe metabolic acidosis is associated with organ dysfunction, and its correction with sodium bicarbonate, alongside treatment of the underlying cause, can be performed safely. Although a mortality benefit remains unlikely based on current evidence, sodium bicarbonate administration may be associated with a reduced need for kidney replacement therapy. Future studies aimed at identifying patient phenotypes that may benefit from this intervention are warranted.
Related
- Sodium bicarbonate therapy in severe metabolic acidemia: an individual patient data meta-analysis of the BICAR-ICU and BICAR-ICU2 trials
- Nutritional and physiological response to feed form and sodium bicarbonate-adjusted dietary electrolyte balance in lactating sows under heat stress.
- Variovorax paradoxus alleviates bicarbonate-induced Fe limitation in cotton by altering the root-associated microbiome
- Bicarbonate-free pH neutralization resensitizes ovarian cancer to chemotherapy and is tracked by 3T CEST MRI
- Physiological Roles of Carbonic Anhydrases and an MpsAB-like Bicarbonate Transporter in Bacillus subtilis
BibTeX
@article{jung2026sodium,
title = {{Sodium bicarbonate for metabolic acidosis}},
author = {Boris Jung and Ary Serpa Neto and Tomoko Fujii},
journal = {Current Opinion in Critical Care},
year = {2026},
month = aug,
doi = {10.1097/mcc.0000000000001425},
url = {https://hal.science/hal-05733565v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Sodium bicarbonate for metabolic acidosis
AU - Boris Jung
AU - Ary Serpa Neto
AU - Tomoko Fujii
PY - 2026
DA - 2026/08/31
JO - Current Opinion in Critical Care
DO - 10.1097/mcc.0000000000001425
UR - https://hal.science/hal-05733565v1
AB - Purpose of review The purpose of this review is to discuss the consequences of severe metabolic acidosis on organ function, examine the physiological controversies surrounding pH correction with sodium bicarbonate, and review the results of recent randomized clinical trials evaluating the effects of sodium bicarbonate on patient-centered outcomes in patients with metabolic acidosis. Recent findings Recent evidence has primarily focused on the results of large multicenter randomized clinical trials, which have shown that sodium bicarbonate administration does not improve mortality in unselected patients with moderate to severe metabolic acidosis, with or without acute kidney injury. However, sodium bicarbonate may delay or reduce the need for kidney replacement therapy in some patients. Summary Severe metabolic acidosis is associated with organ dysfunction, and its correction with sodium bicarbonate, alongside treatment of the underlying cause, can be performed safely. Although a mortality benefit remains unlikely based on current evidence, sodium bicarbonate administration may be associated with a reduced need for kidney replacement therapy. Future studies aimed at identifying patient phenotypes that may benefit from this intervention are warranted.
SN - 1070-5295
ER -